SGRY vs OPCH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SGRY · Surgery Partners$26.78 ▲ 0.34%
OPCH · Option Care Health$31.59 ▼ 0.06%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SGRY +64.4%
- OPCH +5.6%
Head to head
| Metric | SGRY | OPCH |
|---|---|---|
| Price | $26.78 | $31.59 |
| Change today | ▲ 0.34% | ▼ 0.06% |
| Market cap | $3.50B | $4.73B |
| Return, 3 months | +92.0% | +33.5% |
| Return, year to date | +73.3% | -0.8% |
| Return, 1 year | +69.1% | +6.8% |
| P/E (TTM) | – | 22.9 |
| P/B | 2.1 | 3.6 |
| P/E percentile vs own 5y | 54th | 34th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -0.8% | +4.1% |
| Net profit growth (YoY) | -44.3% | +10.8% |
| Gross margin | 22.2% | 19.1% |
| Operating margin | 12.9% | 5.9% |
| Net margin | -2.6% | 3.7% |
| Return on equity | -5.1% | 16.0% |
| Analyst target vs. price | -22.9% | +2.2% |
| Analyst buy share | 14% | 29% |
| RSI (14) | 84 | 69 |
| 30-day volatility | 118.1% | 6.4% |
| Max drawdown, 1 year | -34.0% | -46.7% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- OPCH is the largest of the group by market value.
- SGRY has returned the most over the past year.
- OPCH is growing revenue fastest.
- OPCH keeps the most profit per dollar of sales.
- OPCH has been the calmest stock over the last 30 days.